- Forbes•12 hours ago
Second-quarter earnings season has been going for more than a week, and we’ve had a chance to hear from all four of the biggest companies in biotech as measured by sales, market valuation and clout. Here’s what they had to say in their business updates, along with some commentary from analysts
- TheStreet.com•13 hours ago
Amgen (AMGN) stock is up on Thursday afternoon following the company's solid earnings and revenue results for the 2016 second quarter, and upbeat guidance.
After hours: 171.20-0.08 (-0.05%) as of 7:55 PM EDT
|Bid||170.52 x 100|
|Ask||171.21 x 100|
|52wk Range||130.09 - 181.81|
|Day's Range||166.52 - 171.80|
|Avg Vol (3m)||2,889,806|
As of 4:00 PM EDT. Market closed.